In ALS, TREM2 expression exhibits stage-dependent changes, with upregulation observed in the early and mid-stages of the disease, correlating with a reactive yet neuroprotective microglial phenotype (Jericó et al., 2023). This evidence concerns the gene TREM2 and amyotrophic lateral sclerosis.